Thursday, June 11

Browsing: Sonrotoclax

Treatments

FDA Approves Sonrotoclax in Relapsed/Refractory Mantle Cell Lymphoma

By NewsCancerMay 13, 20260

The NewsThe FDA has granted accelerated approval to sonrotoclax (Beqalzi) as a treatment for patients with relapsed/refractory mantle cell lymphoma…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.